Estimation of Progression-Free Survival for All Treated Patients in the Randomized Discontinuation Trial Design

DOI10.1080/00031305.2012.720900OpenAlexW2000924973WikidataQ42598483 ScholiaQ42598483MaRDI QIDQ5876910FDOQ5876910

Authors: Theodore G. Karrison, Mark J. Ratain, Walter M. Stadler, Gary L. Rosner 

Publication date: 2 February 2023

Published in: The American Statistician (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1080/00031305.2012.720900

zbMATH Keywords

confidence limitsphase II clinical trialsnegative multinomial distributionenrichment design

Mathematics Subject Classification ID

Statistics (62-XX)

Cites Work

• Nonparametric Estimation from Incomplete Observations
• Title not available (Why is that?)
• Survival analysis. Techniques for censored and truncated data
• ON A METHOD OF ESTIMATING FREQUENCIES
• A Confidence Interval for the Median Survival Time
• Confidence Intervals for the Survival Function Using Cox's Proportional- Hazard Model with Covariates
• Bayesian enrichment strategies for randomized discontinuation trials

Cited In (1)

• Trial Size for Near-Optimal Choice Between Surveillance and Aggressive Treatment: Reconsidering MSLT-II

This page was built for publication: Estimation of Progression-Free Survival for All Treated Patients in the Randomized Discontinuation Trial Design

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q5876910)